Cellmover and Red Glead Discovery are awarded 15 Million NOK Eurostars Grant

Prestigious Eurostars program awarded funding to Cellmover and Red Glead Discovery! The grant will support the development of Cellmover’s nanobody-based checkpoint inhibitor therapy against lung cancer. In addition, a macrocyclic peptide approach will be pursued in parallel. “RGD is perfectly...

Read More

Publication in Nature Communications showing that the neuroprotective activity of CDNF is mediated by its interaction with GRP78 protein

Red Glead Discovery is very happy to be a trusted drug discovery partner to Herantis Pharma Plc. Recently, this collaboration resulted in a joint publication in Nature Communications (Springer Nature Group) with additional key contributions from co-authors at EMBL,...

Read More